Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 2,518 | 798 | -1,458 | 4,187 | 2,465 |
| Cost of Goods | 551 | 881 | 287 | 649 | 472 |
| Gross Profit | 1,967 | -83 | -1,744 | 3,537 | 1,993 |
| Operating Expenses | 3,827 | 4,899 | 12,214 | 5,848 | 2,946 |
| Operating Income | -1,309 | -4,101 | -13,672 | -1,661 | -481 |
| Interest Expense | 142 | 145 | 148 | 150 | 153 |
| Other Income | 66 | 14 | 0 | 0 | 460 |
| Pre-tax Income | -1,385 | -4,232 | -13,820 | -1,812 | -174 |
| Income Tax | N/A | N/A | 11 | N/A | N/A |
| Net Income Continuous | -1,385 | -4,221 | -13,830 | -1,812 | -174 |
| Net Income | $-1,385 | $-4,221 | $-13,830 | $-1,812 | $-174 |
| EPS Basic Total Ops | -16.50 | -50.75 | -167.25 | -22.00 | -2.00 |
| EPS Basic Continuous Ops | -16.58 | -50.80 | -167.19 | -21.90 | -2.11 |
| EPS Diluted Total Ops | -16.50 | -50.75 | -167.25 | -22.00 | -2.00 |
| EPS Diluted Continuous Ops | -16.58 | -50.80 | -167.19 | -21.90 | -2.11 |
| EBITDA(a) | $-451 | $-3,068 | $-4,651 | $-101 | $1,080 |